Erschienen in:
01.04.2003 | Clinical Investigations
Percutaneous Interventions in Radiation-Associated Coronary
In-Stent Restenosis
verfasst von:
P. Wexberg, G. Beran, I. Lang, P. Siostrzonek, C. Kirisits, D. Glogar, M. Gottsauner-Wolf
Erschienen in:
CardioVascular and Interventional Radiology
|
Ausgabe 2/2003
Einloggen, um Zugang zu erhalten
Abstract
This study was performed to evaluate the outcome of
percutaneous revascularization in “edge restenoses” developing
after radioactive stent implantation in de novo and in-stent
lesions. Twenty-one consecutive patients undergoing target lesion
revascularization (TLR) at any follow-up after phosphorus-32
radioactive stent implantation were included in this study. We assessed
the incidence of death, myocardial infarction, repeated TLR and
recurrent angina over the following 18 months. After 6 months, TLR rate
was 28.6%, and no stent thromboses, deaths or Q-wave myocardial
infarctions occurred. Among the patients with TLR there were
significantly more subjects who had received a radioactive stent in a
previous in-stent restenosis (66.7% vs. 0% in patients without second
restenosis; P < 0.001), or who had received two
radioactive stents (83.3% vs. 33.3%; P = 0.038).
After 18 months, TLR rate was 33.3%, and two patients (9.5%) had
died. Restenosis after intravascular radiotherapy can be safely treated
by percutaneous interventional techniques, yielding an acceptable
clinical result within 18 months.